(Q36101910)

12 August 2017

A universal vaccine for serogroup B meningococcus (English)

1 reference

12 August 2017

1 reference

29

Rino Rappuoli

1 reference

12 August 2017

30

Mariagrazia Pizza

1 reference

12 August 2017

5

Silvana Savino

1 reference

12 August 2017

17

Vega Masignani

1 reference

12 August 2017

19

Daniele Veggi

1 reference

12 August 2017

6

Laura Santini

1 reference

12 August 2017

4

Beatrice Aricò

1 reference

12 August 2017

3

Maurizio Comanducci

1 reference

12 August 2017

8

Stefania Bambini

1 reference

12 August 2017

7

Brunella Brunelli

1 reference

12 August 2017

2

Jeannette Adu-Bobie

1 reference

12 August 2017

10

Barbara Capecchi

1 reference

12 August 2017

28

Dan Granoff

1 reference

12 August 2017

11

Elena Cartocci

1 reference

12 August 2017

9

Alessia Biolchi

1 reference

12 August 2017

13

Federica Di Marcello

1 reference

12 August 2017

Marzia Monica Giuliani

1

object named as

Marzia M Giuliani

1 reference

12 August 2017

12

Laura Ciucchi

1 reference

12 August 2017

14

Francesca Ferlicca

1 reference

12 August 2017

18

Davide Serruto

1 reference

12 August 2017

20

Mario Contorni

1 reference

12 August 2017

21

Maurizio Morandi

1 reference

12 August 2017

27

Jo Anne Welsch

1 reference

12 August 2017

Barbara Galli

15

1 reference

12 August 2017

Enrico Luzzi

16

1 reference

12 August 2017

Alessandro Bartalesi

22

1 reference

12 August 2017

Vanda Cinotti

23

1 reference

12 August 2017

Donatella Mannucci

24

1 reference

12 August 2017

Francesca Titta

25

1 reference

12 August 2017

Elisa Ovidi

26

1 reference

12 August 2017

language of work or name

English

0 references

publication date

6 July 2006

1 reference

Proceedings of the National Academy of Sciences of the United States of America

12 August 2017

1 reference

12 August 2017

103

1 reference

12 August 2017

10834-10839

1 reference

12 August 2017

29

1 reference

Identification of a universal Group B streptococcus vaccine by multiple genome screen

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Meningococcal polysaccharide-protein conjugate vaccines.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

NadA, a novel vaccine candidate of Neisseria meningitidis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Differences in surface expression of NspA among Neisseria meningitidis group B strains.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Human immunity to the meningococcus. I. The role of humoral antibodies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Experimental disease models for the assessment of meningococcal vaccines.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2047628

Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease

23 September 2018

1 reference

12 December 2020

Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers

1 reference

12 December 2020

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

12 December 2020

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen

1 reference

12 December 2020

Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile

1 reference

12 December 2020

Opinion: Cell entry machines: a common theme in nature?

1 reference

12 December 2020

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

1 reference

12 December 2020

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

1 reference

12 December 2020

A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0603940103

1 reference

12 August 2017

0 references

1 reference

12 August 2017

1 reference